Evidence map›Paper›PMID 23615913›Full record

ArticleThe Journal of biological chemistry2013

Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation.

Sabine S Neukamm, Jennifer Ott, Sascha Dammeier, Rainer Lehmann, Hans-Ulrich Häring, Erwin Schleicher, Cora Weigert

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Etiology of Metabolic Syndrome and Dietary Intervention.International journal of molecular sciences · 2018
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sabine S NeukammDivision of Clinical Chemistry and Pathobiochemistry, Tuebingen 72076, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (Paul Langerhans Institute Tuebingen), Tuebingen, Germany; German Center for Diabetes Research (DZD), Tuebingen 72076, Germany.
Jennifer OttMedical Proteome Center, Institute for Ophtalmic Research, University Hospital Tuebingen, Tuebingen 72076, Germany.
Sascha DammeierMedical Proteome Center, Institute for Ophtalmic Research, University Hospital Tuebingen, Tuebingen 72076, Germany.
Rainer LehmannDivision of Clinical Chemistry and Pathobiochemistry, Tuebingen 72076, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (Paul Langerhans Institute Tuebingen), Tuebingen, Germany; German Center for Diabetes Research (DZD), Tuebingen 72076, Germany.
Hans-Ulrich HäringInstitute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (Paul Langerhans Institute Tuebingen), Tuebingen, Germany; German Center for Diabetes Research (DZD), Tuebingen 72076, Germany; Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Department of Internal Medicine IV, Tuebingen 72076, Germany.
Erwin SchleicherDivision of Clinical Chemistry and Pathobiochemistry, Tuebingen 72076, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (Paul Langerhans Institute Tuebingen), Tuebingen, Germany; German Center for Diabetes Research (DZD), Tuebingen 72076, Germany.
Cora WeigertDivision of Clinical Chemistry and Pathobiochemistry, Tuebingen 72076, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (Paul Langerhans Institute Tuebingen), Tuebingen, Germany; German Center for Diabetes Research (DZD), Tuebingen 72076, Germany. Electronic address: Cora.Weigert@med.uni-tuebingen.de.
Heinrich Heine University Düsseldorf · DEUniversity of Tübingen · DEDeutsches Diabetes-Zentrum e.V. · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin receptor substrate (IRS) 2 as intermediate docking platform transduces the insulin/IGF-1 (insulin like growth factor 1) signal to intracellular effector molecules that regulate glucose homeostasis, β-cell growth, and survival. Previously, IRS2 has been identified as a 14-3-3 interaction protein. 14-3-3 proteins can bind their target proteins via phosphorylated serine/threonine residues located within distinct motifs. In this study the binding of 14-3-3 to IRS2 upon stimulation with forskolin or the cAMP analog 8-(4-chlorophenylthio)-cAMP was demonstrated in HEK293 cells. Binding was reduced with PKA inhibitors H89 or Rp-8-Br-cAMPS. Phosphorylation of IRS2 on PKA consensus motifs was induced by forskolin and the PKA activator N(6)-Phe-cAMP and prevented by both PKA inhibitors. The amino acid region after position 952 on IRS2 was identified as the 14-3-3 binding region by GST-14-3-3 pulldown assays. Mass spectrometric analysis revealed serine 1137 and serine 1138 as cAMP-dependent, potential PKA phosphorylation sites. Mutation of serine 1137/1138 to alanine strongly reduced the cAMP-dependent 14-3-3 binding. Application of cycloheximide revealed that forskolin enhanced IRS2 protein stability in HEK293 cells stably expressing IRS2 as well as in primary hepatocytes. Stimulation with forskolin did not increase protein stability either in the presence of a 14-3-3 antagonist or in the double 1137/1138 alanine mutant. Thus the reduced IRS2 protein degradation was dependent on the interaction with 14-3-3 proteins and the presence of serine 1137/1138. We present serine 1137/1138 as novel cAMP-dependent phosphorylation sites on IRS2 and show their importance in 14-3-3 binding and IRS2 protein stability.

Indexed as

Proteolysis14-3-3 ProteinsAmino Acid SubstitutionAnimalsBinding SitesColforsinCyclic AMPCyclic AMP-Dependent Protein KinasesCycloheximideHEK293 CellsHumansInsulin Receptor Substrate ProteinsMiceMutation, MissensePhosphorylationProtein Binding14-3-3 ProteinsColforsinCyclic AMPCyclic AMP-Dependent Protein KinasesCycloheximideInsulin Receptor Substrate ProteinsIrs2 protein, mouseProtein Synthesis InhibitorsSerine14-3-3Cyclic AMP (cAMP)InsulinIRS2PhosphorylationProtein DegradationProtein Kinase A (PKA)

Identifiers

PMID23615913
PMCPMC3675577
OpenAlexW2080784571

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.